Louis Navellier and the InvestorPlace Research Staff

Louis Navellier and the InvestorPlace Research Staff

New York Times
An icon among growth stock investors

About Louis Navellier and the InvestorPlace Research Staff

Louis Navellier is one of Wall Street’s renowned growth investors. Providing investment advice to tens of thousands of investors for more than three decades, he has earned a reputation as a savvy stock picker and unrivaled portfolio manager.

Over his 35-year investing career, Louis Navellier has established one of the most exceptional long-term track records of any financial newsletter editor in America, and he offers a wide range of simple yet powerful tools that can help all investors to significantly beat the market.

His popular Growth Investor advisory service, established in 1998, has beaten the S&P 500 by a margin of 3-to-1 over the past 17 years.

Navellier continues to build on those stellar records, and while his methodology is rigorous and complex, his goal has been simple, and has been so from the beginning: to uncover Wall Street’s inconsistencies and help investors beat the market with less risk in the market’s best growth stocks. Today, he helps individual investors across the nation and across the globe achieve their financial dreams through his unique newsletter services.

The New York Times called Mr. Navellier “an icon among growth stock investors,” and the media frequently turns to Louis for his expert opinion. He appears regularly on CNBC and Fox Business News and is frequently quoted by MarketWatch, Bloomberg and The Wall Street Journal.

Navellier is an accomplished Wall Street insider as well. He and his team of more than 50 professional analysts and staff manage over $5 billion in mutual funds and institutional accounts through his fund management company, Navellier & Associates.

Louis Navellier also travels the country hosting free seminars for individual investors, and is the author of The Little Book That Makes You Rich, named one of the Top 10 Investing Books of 2007 by SFO Magazine.

Premium Services

Louis Navellier’s Growth Investor provides an expert’s take on the latest market trends and opportunities. Then Louis shares his picks of High-Growth Investments and Elite Dividend Payers — complete with volatility ratings and buy-below prices.

  • Stocks (Mid- to Large-Cap)

  • Conservative

  • Monthly trades

Learn More

Already a member? Login here

If you want growth, you’ve got to look at smaller up-and-comers that aren’t as well-known... yet. Louis Navellier’s Breakthrough Stocks lets you participate in high-quality small-caps — according to your personal risk tolerance.

  • Stocks (Small to Mid-Cap)

  • Moderate to Aggressive

  • Monthly trades

Learn More

Already a member? Login here

Accelerated Profits uses Louis Navellier’s proprietary stock-rating system to identify High Velocity and Ultimate Growth Trades. By combining the “one-two punch” of strong momentum and fundamentals with a more frequent trading schedule, you get significant returns... in a fraction of the time.

  • Stocks (Large-Cap)

  • Aggressive

  • Weekly trades

Learn More

Already a member? Login here

Louis Navellier’s Platinum Growth combines the top-notch investing strategies of Growth Investor and Breakthrough Stocks with the faster pace of Accelerated Profits — all in a powerful new way that could improve your results 10-fold or better.

  • Stocks

  • Conservative to Aggressive

  • Weekly and monthly trades

Learn More

Already a member? Login here

Recent Articles

Evolving eBay Will Continue to Post Strong Growth Numbers

It's not as flashy as newer e-commerce names, so eBay has a tendency to be overlooked. But you shouldn't discount EBAY stock right now.

Big Catalysts Are Just Around the Corner for iBio Stock

Asset prices don't go up in a straight line, even if the company shows promise. Use the dip in IBIO stock now to get in at a favorable price.

Intuit Stock Is a Resilient Tax-Time Holding

Tax season has a different timetable in the year of the coronavirus, and INTU stock's value should appreciate this summer and beyond.

Remark Stock Is a Strong Play on Vital Thermal Imaging Technology

As a way to capitalize on state-of-the-art coronavirus scanning technology, MARK stock gets high marks as the company continues to innovate.

AbbVie Remains One of the Safest Pharma Investments You Can Make

The pharmaceutical market has its ups and downs, but that doesn't mean every investment is risky as ABBV stock is a reasonably safe bet.